Silence Therapeutics (SLN) Research & Development (2020 - 2025)
Historic Research & Development for Silence Therapeutics (SLN) over the last 7 years, with Q3 2025 value amounting to $20.5 million.
- Silence Therapeutics' Research & Development rose 190.98% to $20.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $81.1 million, marking a year-over-year decrease of 4320.31%. This contributed to the annual value of $67.9 million for FY2024, which is 1922.48% up from last year.
- As of Q3 2025, Silence Therapeutics' Research & Development stood at $20.5 million, which was up 190.98% from $17.6 million recorded in Q2 2025.
- Silence Therapeutics' Research & Development's 5-year high stood at $97.0 million during Q4 2023, with a 5-year trough of -$10.3 billion in Q1 2021.
- Its 5-year average for Research & Development is -$527.0 million, with a median of $11.8 million in 2024.
- In the last 5 years, Silence Therapeutics' Research & Development soared by 37433.05% in 2021 and then plummeted by 7722.85% in 2024.
- Quarter analysis of 5 years shows Silence Therapeutics' Research & Development stood at $73.2 million in 2021, then grew by 0.64% to $73.7 million in 2022, then surged by 31.6% to $97.0 million in 2023, then crashed by 77.23% to $22.1 million in 2024, then decreased by 6.94% to $20.5 million in 2025.
- Its last three reported values are $20.5 million in Q3 2025, $17.6 million for Q2 2025, and $20.8 million during Q1 2025.